Skip to main content
BEIJING TONG REN TANG CO., LTD logo

BEIJING TONG REN TANG CO., LTD — Investor Relations & Filings

Ticker · 600085 ISIN · CNE000000R69 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600085

About BEIJING TONG REN TANG CO., LTD

https://cm.tongrentang.com/en/

Beijing Tong Ren Tang Co., Ltd. specializes in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1669, the company produces a wide range of products, including Chinese patent medicines, health foods, and herbal decoctions. Key offerings include Angong Niuhuang Wan, Liuwei Dihuang Wan, and Wuji Baifeng Wan. The company is recognized for its commitment to traditional pharmaceutical techniques and rigorous quality control standards, often summarized by its philosophy of not sparing labor or materials regardless of cost. By combining ancient herbal wisdom with modern scientific technology, the organization provides healthcare products and services to both domestic and international markets, maintaining a reputation for authenticity and clinical efficacy.

Recent filings

Filing Released Lang Actions
同仁堂 关于控股孙公司同仁堂国药获得香港中成药注册证明书的公告
Regulatory Filings Classification · 87% confidence The document is a company announcement regarding its subsidiary obtaining a product registration certificate in Hong Kong. It does not present financial statements, management or board changes, earnings results, or proxy materials. It is a general regulatory disclosure of a non-financial development. Therefore, it falls under the catch-all Regulatory Filings category.
2026-05-26 Chinese
同仁堂2025年年度股东会会议资料
AGM Information Classification · 95% confidence The document consists entirely of the “2025年年度股东会会议资料” (2025 Annual General Meeting materials) for Beijing Tong Ren Tang Co., Ltd., including meeting notices, agendas, and the full set of proposals (annual report, profit distribution plan, board report, remuneration plan, etc.) presented at the AGM. It is clearly preparatory materials for the Annual General Meeting, matching the definition of AGM Information (Code: AGM-R).
2026-05-26 Chinese
同仁堂 关于召开2025年年度股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice convening the company’s 2025 Annual General Meeting. It provides the meeting date, agenda items, voting instructions including proxy form, and solicits shareholder votes. It is not the full annual report itself, nor a post‐meeting voting results announcement, nor simply a link announcement. It is a proxy solicitation/information statement sent to shareholders to provide information and request votes, fitting the PSI category.
2026-05-26 Chinese
同仁堂 第十届董事会第二十二次会议决议公告
Regulatory Filings Classification · 78% confidence The document is an announcement of resolutions passed at the 22nd meeting of the 10th Board of Directors. It does not present financial data (so not an Annual or Interim report), nor is it announcing a report’s publication. It is not a proxy statement, nor an earnings release, nor an ESG report. It is a regulatory compliance announcement summarizing board meeting outcomes and votes, which does not fit any more specific category. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-05-26 Chinese
同仁堂 关于控股子公司同仁堂商业终止对红惠医药投资的公告
Capital/Financing Update Classification · 75% confidence The document is a formal Shanghai Stock Exchange style announcement (‘公告’) by Beijing Tongrentang Co., Ltd. detailing the termination of a planned equity acquisition by its subsidiary, including board resolutions, agreements, valuation report and effects on the company. It is not a full financial report (10-K or interim report), nor a call transcript, proxy, or ESG disclosure. It relates to changes in the company’s financing/investment activities (stopping the capital investment and reversing the equity transfer). Therefore, it best fits the Capital/Financing Update category (CAP).
2026-05-26 Chinese
同仁堂2025年度“提质增效重回报”行动方案年度评估报告
Management Reports Classification · 95% confidence The document is titled as an "Annual Evaluation Report" for the 2025 year, issued by Beijing Tongrentang Co., Ltd. It provides a comprehensive review of the company's operational performance, strategic initiatives, governance, investor relations, innovation, and risk outlook for the full fiscal year 2025. It includes audited financial figures such as total assets, equity, revenue, and net profit, along with detailed narrative on business operations, shareholder returns, innovation, governance, and future outlook. The length of the document (6645 characters) and the detailed content with financial data and management discussion indicate this is a substantive report rather than a brief announcement or certification. The document does not appear to be a standard Annual Report (10-K) but rather a specialized annual evaluation report related to a specific strategic action plan called "提质增效重回报" (Quality Improvement, Efficiency Enhancement, and Return to Shareholders). It is a comprehensive management report assessing the execution and results of this action plan for the year 2025, including financial performance, governance, and investor relations. This fits best under the category of Management Reports (MDA), which covers management's detailed explanation of financial results, business trends, and outlook. It is not a simple earnings release, regulatory filing, or governance report, but a detailed management assessment report. Therefore, the appropriate classification is MDA with high confidence.
2026-03-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.